MD, resident fellow, American Enterprise Institute
It’s been five months since he resigned, and former FDA commissioner Scott Gottlieb is still driving national discussions around topics such as nicotine, vaping and CBD.
Of course, prior to resigning, Gottlieb was arguably the leading influencer in healthcare, shaping debate in ways that previous commissioners had not. During his tenure he streamlined drug approvals, attacked drug prices via competition from generics and biosimilars and focused publicly on the dangers of e-cigarettes.
Post-government, Gottlieb accepted a position on Pfizer’s board. And given his comms skills, Gottlieb will no doubt continue adding to the debate around healthcare as a resident fellow at the American Enterprise Institute and a biopharmaceutical consultant.